Pinnacle Wealth Planning Services’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.47K Hold
949
– – ﹤0.01% 2232
2026
Q2
$8.9K Hold
949
– – ﹤0.01% 2114
2026
Q1
$8.91K Hold
949
– – ﹤0.01% 2050
2025
Q4
$7.72K Buy
+949
New +$11.7K ﹤0.01% 2117

Other funds holding CRBP

Pinnacle Wealth Planning Services's CRBP Position: Q3 2026 in Review

Pinnacle Wealth Planning Services held its Corbus Pharmaceuticals (CRBP) position steady in Q3 2026 at 949 shares worth $6.47K. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Pinnacle Wealth Planning Services first reported a position in CRBP in Q4 2025 and has held it in 4 quarters since. The position peaked at $8.91K in Q1 2026. 120 funds tracked by Wall St. Rank hold CRBP as of Q3 2026.

  • Pinnacle Wealth Planning Services held 949 shares of Corbus Pharmaceuticals worth $6.47K as of Q3 2026.
  • Pinnacle Wealth Planning Services left its Corbus Pharmaceuticals share count unchanged in Q3 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #2232 holding.
  • Pinnacle Wealth Planning Services first reported a position in Corbus Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Pinnacle Wealth Planning Services's Corbus Pharmaceuticals position peaked at $8.91K in Q1 2026.
  • 120 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.